Stay updated on Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded: Revision: v3.4.2. Removed: Notice about government funding and operating status. These are maintenance updates to the ClinicalTrials.gov site and do not affect study data or user actions.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and an updated revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdministrative UI and metadata updates were made (glossary toggle, QC-related labels, FEAR Act wording, and a new version revision). These changes do not affect the study content, eligibility criteria, or trial results.SummaryDifference0.3%

- Check55 days agoChange DetectedKey sections such as sponsor/investigators, study locations, eligibility criteria, and primary outcomes appear removed or collapsed. The page's detailed trial information is notably reduced, affecting how a user would assess participation and reach the study team.SummaryDifference15%

- Check62 days agoChange DetectedThe page shows a new Revision: v3.3.4 and removal of v3.3.3; no changes to core study data or human subjects details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.